Sponsor pipeline

Stelexis BioSciences clinical trial pipeline

Get alerts when Stelexis BioSciences's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    Primary endpoint(s) modified

    Also in this update: Primary completion pushed from Jul 15, 2027 to Dec 15, 2027; Enrollment reduced: 125 → 105 participants

    Stelexis BioSciencesPhase 1 NCT06533761 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2

Disease areas by active trials

Acute Myeloid Leukemia (AML) (1) · Leukemia (1) · Myelodysplastic Syndromes (MDS) (1)

Get alerts when Stelexis BioSciences's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free